New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
05:41 EDTAETAetna downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded Aetna to Neutral citing less favorable sector trends. The firm lowered its price target for shares to $88 from $91.
News For AET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 28, 2015
08:46 EDTAETOn The Fly: Pre-market Movers
Subscribe for More Information
06:05 EDTAETAetna reports total medical membership totaled 23.67M at March 31, 2015
Subscribe for More Information
06:04 EDTAETAetna reports Q1 Health Care business operating earnings $835.6M
Subscribe for More Information
06:02 EDTAETAetna raises FY15 operating EPS to $7.20-$7.40 from at least $7.00
Subscribe for More Information
06:02 EDTAETAetna reports Q1 operating EPS $2.39, consensus $1.95
Subscribe for More Information
April 27, 2015
15:04 EDTAETNotable companies reporting before tomorrow's open
Subscribe for More Information
13:27 EDTAETAetna technical comments ahead of earnings
Subscribe for More Information
13:15 EDTAETEarnings Watch: Aetna to report Q1 results amid continued membership growth
Aetna (AET) is scheduled to report first quarter earnings before the market open on Tuesday, April 28 with a conference call scheduled for 8:00 am ET. Aetna operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. EXPECTATIONS: Analysts are looking for earnings per share of $1.95 on revenue of $15.46B, according to First Call. The consensus range for EPS is $1.87-$2.13 on revenue of $15.08B-$16.0B. LAST QUARTER: Aetna reported fourth quarter EPS of $1.22, which was in-line with consensus estimates, on revenue of $14.77B against estimates of $14.6B. The company raised its fiscal 2015 EPS view to at least $7.00, against consensus estimates at the time of $7.16. "Aetna achieved record annual operating revenue and operating earnings in 2014, and delivered full-year operating earnings per share at the high end of our most recent projection," said Aetna chairman and CEO Mark Bertolini. "Our 2014 operating earnings-per-share results represent an increase of more than 7% over 2013 and a compound annualized growth rate of 15% since 2010. We also ended the year serving more than 23.5M medical members, an increase of approximately 1.4M members from 2013." STREET RESEARCH: On March 19, Sterne Agee upgraded Aetna to Buy from Neutral. The firm says that the company is the best-positioned name within the large-cap health plan space, a defensive sector that has little exposure to Europe and reasonable growth prospects, according to the firm. On March 12, Argus increased its price target on Aetna to $115 from $103 after Aetna's Q4 membership growth exceeded its prior targets. The firm said it thinks the company will deliver sustained membership and revenue growth in 2015. It kept a Buy rating on the stock. PRICE ACTION: Aetna shares are up approximately 17% since the company's last earnings report on February 3 and are down over 1% in afternoon trading ahead of Tuesday morning's earnings.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use